| Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease |
32 |
| CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1 |
31 |
| Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1-and Rac1-induced autophagy |
30 |
| Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway |
30 |
| Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells |
28 |
| Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b |
24 |
| Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy |
19 |
| Resident fibroblast expansion during cardiac growth and remodeling |
19 |
| Sestrin2 prevents age-related intolerance to post myocardial infarction via AMPK/PGC-1 alpha pathway |
18 |
| Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues |
18 |
| The emerging landscape of circular RNA in cardiovascular diseases |
17 |
| LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA |
16 |
| Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH |
16 |
| Development of calcific aortic valve disease: Do we know enough for new clinical trials? |
16 |
| Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis |
15 |
| Ca2+ handling remodeling and STIM1L/Orail/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy |
15 |
| Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-beta-induced endothelial-mesenchymal transition and cardiac fibrosis |
14 |
| Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo |
14 |
| Programmed necrosis in heart disease: Molecular mechanisms and clinical implications |
14 |
| Melatonin attenuates chronic pain related myocardial ischemic susceptibility through inhibiting RIP3-MLKL/CaMKII dependent necroptosis |
14 |
| Echocardiographic evaluation of diastolic function in mouse models of heart disease |
14 |
| Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK |
13 |
| Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3 beta RISK pathway |
13 |
| Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy |
13 |
| Brgl trans-activates endothelium-derived colony stimulating factor to promote calcium chloride induced abdominal aortic aneurysm in mice |
13 |
| High phosphate-induced downregulation of PPAR gamma contributes to CKD-associated vascular calcification |
12 |
| Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome |
12 |
| Decreased ATP production and myocardial contractile reserve in metabolic heart disease |
12 |
| MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1 |
12 |
| MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages |
12 |
| beta-adrenergic regulation of late Na+ current during cardiac action potential is mediated by both PKA and CaMKII |
12 |
| A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes |
12 |
| MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells |
11 |
| Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis |
11 |
| Histone deacetylases in cardiovascular and metabolic diseases |
11 |
| Cardiomyocyte cell cycle dynamics and proliferation revealed through cardiac-specific transgenesis of fluorescent ubiquitinated cell cycle indicator (FUCCI) |
11 |
| Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease |
11 |
| DNA methyltransferase 1 and Kruppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis |
11 |
| Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro -arrhythmic action potential changes in human iPSC cardiomyocytes |
11 |
| SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function |
11 |
| Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
11 |
| Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/beta-catenin pathway and PPAR gamma |
10 |
| Shear stress: An essential driver of endothelial progenitor cells |
10 |
| A long noncoding RNA NR_045363 controls cardiomyocyte proliferation and cardiac repair |
10 |
| CTGF/CCN2 is an autocrine regulator of cardiac fibrosis |
10 |
| Mitochondrial fission protein, dynamin-related protein contributes to the promotion of hypertensive cardiac hypertrophy and fibrosis in Dahl-salt sensitive rats |
10 |
| Necroptosis in cardiovascular disease - a new therapeutic target |
10 |
| Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-beta 1 signaling |
10 |
| The unfolded protein response in ischemic heart disease |
10 |
| LncRNA NKILA regulates endothelium inflammation by controlling a NF-kappa B/KLF4 positive feedback loop |
10 |
